BGSF, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BGSF, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $22.03M | Mar 30, 2026 |
| FY2025 | Sep 28, 2025 | $26.90M | Mar 30, 2026 |
| FY2025 | Jun 29, 2025 | $23.51M | Mar 30, 2026 |
| FY2025 | Mar 30, 2025 | $20.88M | Mar 30, 2026 |
| FY2025 | Dec 29, 2024 | $24.31M | Mar 30, 2026 |
| FY2025 | Sep 29, 2024 | $29.82M | Mar 30, 2026 |
| FY2025 | Jun 30, 2024 | $25.73M | Mar 30, 2026 |
| FY2025 | Mar 31, 2024 | $24.55M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $73.57M | Mar 17, 2025 |
| FY2024 | Oct 1, 2023 | $83.48M | Mar 17, 2025 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $7.70M | Mar 30, 2026 |
| FY2025 | Sep 28, 2025 | $9.66M | Mar 30, 2026 |
| FY2025 | Jun 29, 2025 | $8.41M | Mar 30, 2026 |
| FY2025 | Mar 30, 2025 | $7.56M | Mar 30, 2026 |
| FY2025 | Dec 29, 2024 | $8.73M | Mar 30, 2026 |
| FY2025 | Sep 29, 2024 | $10.70M | Mar 30, 2026 |
| FY2025 | Jun 30, 2024 | $9.60M | Mar 30, 2026 |
| FY2025 | Mar 31, 2024 | $9.34M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $25.45M | Mar 17, 2025 |
| FY2024 | Oct 1, 2023 | $29.98M | Mar 17, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | ($1.16M) | Mar 30, 2026 |
| FY2025 | Sep 28, 2025 | ($5.81M) | Mar 30, 2026 |
| FY2025 | Jun 29, 2025 | ($3.74M) | Mar 30, 2026 |
| FY2025 | Mar 30, 2025 | ($722.0K) | Mar 30, 2026 |
| FY2025 | Dec 29, 2024 | ($981.0K) | Mar 30, 2026 |
| FY2025 | Sep 29, 2024 | ($804.0K) | Mar 30, 2026 |
| FY2025 | Jun 30, 2024 | ($761.0K) | Mar 30, 2026 |
| FY2025 | Mar 31, 2024 | ($792.0K) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $999.0K | Mar 17, 2025 |
| FY2024 | Oct 1, 2023 | $2.64M | Mar 17, 2025 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | ($8.90M) | Mar 30, 2026 |
| FY2025 | Dec 29, 2024 | ($5.87M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2023 | $3.07M | Mar 30, 2026 |
| FY2024 | Jan 1, 2023 | $16.28M | Mar 17, 2025 |
| FY2022 | Dec 26, 2021 | $14.53M | Mar 15, 2024 |
| FY2022 | Dec 27, 2020 | ($1.23M) | Mar 16, 2023 |
| FY2021 | Dec 29, 2019 | $14.89M | Mar 10, 2022 |
| FY2020 | Dec 30, 2018 | $24.26M | Mar 11, 2021 |
| FY2019 | Dec 31, 2017 | $17.76M | Mar 12, 2020 |
| FY2018 | Dec 25, 2016 | $15.54M | Mar 12, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $41.14M | Mar 30, 2026 |
| FY2025 | Dec 29, 2024 | $42.90M | Mar 30, 2026 |
| FY2025 | Dec 31, 2023 | $45.40M | Mar 30, 2026 |
| FY2024 | Jan 1, 2023 | $83.21M | Mar 17, 2025 |
| FY2022 | Dec 26, 2021 | $65.12M | Mar 15, 2024 |
| FY2022 | Dec 27, 2020 | $55.24M | Mar 16, 2023 |
| FY2021 | Dec 29, 2019 | $50.22M | Mar 10, 2022 |
| FY2020 | Dec 30, 2018 | $51.07M | Mar 11, 2021 |
| FY2019 | Dec 31, 2017 | $44.58M | Mar 12, 2020 |
| FY2018 | Dec 25, 2016 | $37.80M | Mar 12, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $142.0K | Mar 30, 2026 |
| FY2025 | Dec 29, 2024 | $24.38M | Mar 30, 2026 |
| FY2025 | Dec 31, 2023 | $20.39M | Mar 30, 2026 |
| FY2024 | Jan 1, 2023 | ($7.12M) | Mar 17, 2025 |
| FY2022 | Dec 26, 2021 | $6.66M | Mar 15, 2024 |
| FY2022 | Dec 27, 2020 | $22.26M | Mar 16, 2023 |
| FY2021 | Dec 29, 2019 | $17.95M | Mar 10, 2022 |
| FY2020 | Dec 30, 2018 | $18.43M | Mar 11, 2021 |
| FY2019 | Dec 31, 2017 | $18.06M | Mar 12, 2020 |
| FY2018 | Dec 25, 2016 | $9.53M | Mar 12, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $57.84M | Mar 30, 2026 |
| FY2025 | Dec 29, 2024 | $150.11M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $178.52M | Mar 17, 2025 |
| FY2022 | Jan 1, 2023 | $194.67M | Mar 15, 2024 |
| FY2022 | Dec 26, 2021 | $148.29M | Mar 16, 2023 |
| FY2021 | Dec 27, 2020 | $130.28M | Mar 10, 2022 |
| FY2020 | Dec 29, 2019 | $115.59M | Mar 11, 2021 |
| FY2019 | Dec 30, 2018 | $100.27M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $104.63M | Mar 12, 2019 |
| FY2017 | Dec 25, 2016 | $81.21M | Mar 8, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $9.73M | Mar 30, 2026 |
| FY2025 | Dec 29, 2024 | $67.84M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $92.98M | Mar 17, 2025 |
| FY2022 | Jan 1, 2023 | $93.94M | Mar 15, 2024 |
| FY2022 | Dec 26, 2021 | $71.70M | Mar 16, 2023 |
| FY2021 | Dec 27, 2020 | $64.82M | Mar 10, 2022 |
| FY2020 | Dec 29, 2019 | $47.13M | Mar 11, 2021 |
| FY2019 | Dec 30, 2018 | $34.57M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $65.50M | Mar 12, 2019 |
| FY2017 | Dec 25, 2016 | $40.73M | Mar 8, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $48.11M | Mar 30, 2026 |
| FY2025 | Dec 29, 2024 | $82.27M | Mar 30, 2026 |
| FY2025 | Dec 31, 2023 | $85.54M | Mar 30, 2026 |
| FY2025 | Jan 1, 2023 | $100.74M | Mar 30, 2026 |
| FY2024 | Dec 26, 2021 | $76.59M | Mar 17, 2025 |
| FY2022 | Dec 27, 2020 | $65.46M | Mar 15, 2024 |
| FY2022 | Dec 29, 2019 | $68.46M | Mar 16, 2023 |
| FY2021 | Dec 30, 2018 | $65.70M | Mar 10, 2022 |
| FY2020 | Dec 31, 2017 | $39.13M | Mar 11, 2021 |
| FY2019 | Dec 25, 2016 | $40.49M | Mar 12, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $1.07M | Mar 30, 2026 |
| FY2025 | Dec 29, 2024 | $1.07M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $59.59M | Mar 17, 2025 |
| FY2024 | Jan 1, 2023 | $55.19M | Mar 17, 2025 |
| FY2022 | Dec 26, 2021 | $29.14M | Mar 15, 2024 |
| FY2022 | Dec 27, 2020 | $27.05M | Mar 16, 2023 |
| FY2021 | Dec 29, 2019 | $20.17M | Mar 10, 2022 |
| FY2020 | Dec 30, 2018 | $17.98M | Mar 11, 2021 |
| FY2019 | Dec 31, 2017 | $17.97M | Mar 12, 2020 |
| FY2018 | Dec 25, 2016 | $9.18M | Mar 12, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | ($21.87M) | Mar 30, 2026 |
| FY2025 | Dec 29, 2024 | $11.96M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $16.93M | Mar 17, 2025 |
| FY2022 | Jan 1, 2023 | $33.66M | Mar 15, 2024 |
| FY2022 | Dec 26, 2021 | $14.59M | Mar 16, 2023 |
| FY2021 | Dec 27, 2020 | $5.05M | Mar 10, 2022 |
| FY2020 | Dec 29, 2019 | $8.76M | Mar 11, 2021 |
| FY2019 | Dec 30, 2018 | $8.00M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $1.37M | Mar 12, 2019 |
| FY2017 | Dec 25, 2016 | $4.26M | Mar 8, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 30, 2018 | $0 | Mar 12, 2019 |
| FY2018 | Dec 31, 2017 | $0 | Mar 12, 2019 |
| FY2018 | Dec 25, 2016 | $0 | Mar 12, 2019 |
| FY2018 | Dec 27, 2015 | $0 | Mar 12, 2019 |
| FY2017 | Dec 28, 2014 | $0 | Mar 8, 2018 |
| FY2016 | Dec 29, 2013 | $0 | Mar 6, 2017 |
| FY2014 | Dec 30, 2012 | $0 | Mar 2, 2015 |
| FY2013 | Dec 25, 2011 | $0 | Mar 31, 2014 |
| FY2013 | Dec 25, 2010 | $0 | Mar 31, 2014 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 27, 2015 | $14.61M | Mar 7, 2016 |
| FY2015 | Dec 28, 2014 | $16.89M | Mar 7, 2016 |
| FY2014 | Dec 29, 2013 | $19.38M | Mar 2, 2015 |
| FY2013 | Dec 30, 2012 | $16.62M | Mar 31, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | 0 | Mar 30, 2026 |
| FY2025 | Sep 28, 2025 | 0 | Mar 30, 2026 |
| FY2025 | Jun 29, 2025 | 0 | Mar 30, 2026 |
| FY2025 | Mar 30, 2025 | 0 | Mar 30, 2026 |
| FY2025 | Dec 29, 2024 | 0 | Mar 30, 2026 |
| FY2025 | Sep 29, 2024 | 0 | Mar 30, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Mar 30, 2026 |
| FY2025 | Mar 31, 2024 | 0 | Mar 30, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 30, 2026 |
| FY2022 | Jan 1, 2023 | 0 | Mar 15, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | 0 | Mar 30, 2026 |
| FY2025 | Sep 28, 2025 | 0 | Mar 30, 2026 |
| FY2025 | Jun 29, 2025 | 0 | Mar 30, 2026 |
| FY2025 | Mar 30, 2025 | 0 | Mar 30, 2026 |
| FY2025 | Dec 29, 2024 | 0 | Mar 30, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 30, 2026 |
| FY2022 | Jan 1, 2023 | 0 | Mar 15, 2024 |
| FY2022 | Sep 25, 2022 | 0 | Mar 15, 2024 |
| FY2022 | Jun 26, 2022 | 0 | Mar 15, 2024 |
| FY2022 | Mar 27, 2022 | 1 | Mar 15, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | 11.23M | Mar 30, 2026 |
| FY2024 | Dec 29, 2024 | 11.04M | Mar 17, 2025 |
| FY2022 | Dec 31, 2023 | 10.89M | Mar 15, 2024 |
| FY2022 | Jan 1, 2023 | 10.77M | Mar 16, 2023 |
| FY2022 | Dec 26, 2021 | 2,022 | Mar 16, 2023 |
| FY2021 | Dec 27, 2020 | 10.33M | Mar 10, 2022 |
| FY2020 | Dec 29, 2019 | 10.31M | Mar 11, 2021 |
| FY2019 | Dec 30, 2018 | 10.23M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | 8.76M | Mar 12, 2019 |
| FY2017 | Dec 25, 2016 | 8.67M | Mar 8, 2018 |